QuidelOrtho Corp
QDELdata completeness 100%6 fiscal years on fileQuidelOrtho Corp earns about 4% on invested capital, but has diluted owners by 58% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2022 | FY 2023 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $1.7B1 | $3.27B1 | $3B1 | $2.78B2 | $2.73B2 |
| Net income | $704.2M3 | $548.7M4 | −$10.1M5 | −$2.05B5 | −$1.13B5 |
| Operating cash flow | $805.9M6 | $885.3M7 | $280.2M8 | $83M8 | $105.2M8 |
| Capital expenditure | $292.8M9 | $140.9M10 | $209.3M11 | $195.1M11 | $188.2M11 |
| Free cash flow (derived) | $513.1M6 | $744.4M7 | $70.9M8 | −$112.1M8 | −$83M8 |
| Total debt | $600,00012 | $3.06B13 | $2.7B14 | $3.17B15 | $3.05B15 |
| Cash & equivalents | $802.8M16 | $292.9M17 | $118.9M18 | $98.3M19 | $169.8M19 |
| Diluted shares | 42.9M | 57.4M | 66.8M | 67.2M | 67.8M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $283.26 of net worth that earned you −$166.93 and generated −$12.24 of cash last year, against $450.49 of debt.
It earned an average 4% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 58% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has risen 508950% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K/A · period ending 2022-01-02 · accession 0001906324-24-000043 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2024-12-29 · accession 0001906324-26-000008 (Revenues)
- 10-K/A · period ending 2022-01-02 · accession 0001906324-24-000043 (NetIncomeLoss)
- 10-K · period ending 2023-01-01 · accession 0001906324-25-000035 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001906324-26-000008 (NetIncomeLoss)
- 10-K/A · period ending 2022-01-02 · accession 0001906324-24-000043 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-01-01 · accession 0001906324-25-000035 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001906324-26-000008 (NetCashProvidedByUsedInOperatingActivities)
- 10-K/A · period ending 2022-01-02 · accession 0001906324-24-000043 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-01-01 · accession 0001906324-25-000035 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001906324-26-000008 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-01-02 · accession 0001906324-23-000014 (LongTermDebtCurrent)
- 10-K/A · period ending 2023-01-01 · accession 0001906324-24-000043 (LongTermDebtCurrent)
- 10-K · period ending 2023-12-31 · accession 0001906324-25-000035 (LongTermDebtCurrent)
- 10-K · period ending 2024-12-29 · accession 0001906324-26-000008 (LongTermDebtCurrent)
- 10-K · period ending 2022-01-02 · accession 0001906324-23-000014 (CashAndCashEquivalentsAtCarryingValue)
- 10-K/A · period ending 2023-01-01 · accession 0001906324-24-000043 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001906324-25-000035 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-29 · accession 0001906324-26-000008 (CashAndCashEquivalentsAtCarryingValue)